| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PSC.2973 |
| P698 | PubMed publication ID | 28120548 |
| P50 | author | Shashank Shekhar | Q61157930 |
| P2093 | author name string | Sharmistha Dey | |
| Immaculata Xess | |||
| Kusum Singh | |||
| Yudhishthir Yadav | |||
| P2860 | cites work | Antimicrobial peptides for therapeutic applications: a review | Q27004635 |
| Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? | Q29547675 | ||
| Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study | Q29616607 | ||
| Epidemiology of invasive candidiasis: a persistent public health problem | Q29616758 | ||
| Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies | Q29617810 | ||
| Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008. | Q30574840 | ||
| Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. | Q30580647 | ||
| Discovery of Short Peptides Exhibiting High Potency against Cryptococcus neoformans | Q33636123 | ||
| In vitro antifungal activity of hydroxychavicol isolated from Piper betle L. | Q33736959 | ||
| Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study | Q34195380 | ||
| Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? | Q34359245 | ||
| Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources | Q34453558 | ||
| The structure and synthesis of the fungal cell wall | Q34559828 | ||
| Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms. | Q34923389 | ||
| Candida biofilms and their role in infection | Q35044563 | ||
| Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers | Q35073043 | ||
| Structure-activity relationship study of novel peptoids that mimic the structure of antimicrobial peptides | Q35622159 | ||
| Newer combination antifungal therapies for invasive aspergillosis. | Q35642204 | ||
| Peptide antimicrobial agents | Q36538861 | ||
| Multi-target therapeutics: when the whole is greater than the sum of the parts | Q36697412 | ||
| Extension growth of the water mold Achlya: interplay of turgor and wall strength | Q36999200 | ||
| Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole | Q37736120 | ||
| Cationic antimicrobial peptides in clinical development, with special focus on thanatin and heliomicin. | Q37941452 | ||
| The antifungal protein from Aspergillus giganteus causes membrane permeabilization | Q39740573 | ||
| The antifungal protein AFP from Aspergillus giganteus inhibits chitin synthesis in sensitive fungi | Q42222332 | ||
| The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan | Q43168990 | ||
| Antimicrobial efficacy of eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures. | Q43259562 | ||
| SD-8, a novel therapeutic agent active against multidrug-resistant Gram positive cocci | Q44032645 | ||
| Purification of alpha-sarcin and an antifungal protein from mold (Aspergillus giganteus) by chitin affinity chromatography | Q44032845 | ||
| Attributable mortality of nosocomial candidemia, revisited | Q44386169 | ||
| Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan-containing hexapeptides | Q44974410 | ||
| De novo generation of short antimicrobial peptides with enhanced stability and cell specificity | Q47777488 | ||
| A robustness-based approach to systems-oriented drug design. | Q51062307 | ||
| Epidemiology of candida bloodstream infections in a tertiary care institute in India. | Q51834105 | ||
| P433 | issue | 3 | |
| P921 | main subject | Candida tropicalis | Q143138 |
| P304 | page(s) | 228-235 | |
| P577 | publication date | 2017-01-25 | |
| P1433 | published in | Journal of Peptide Science | Q3186932 |
| P1476 | title | DS6: anticandidal, antibiofilm peptide against Candida tropicalis and exhibit synergy with commercial drug | |
| P478 | volume | 23 |
| Q91650098 | Antifungal Peptides as Therapeutic Agents |
| Q59794490 | Antifungal and anti-biofilm activity of the first cryptic antimicrobial peptide from an archaeal protein against Candida spp. clinical isolates |
| Q98178327 | Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy |
| Q48102059 | Antimicrobial activity of denture adhesive associated with Equisetum giganteum- and Punica granatum-enriched fractions against Candida albicans biofilms on acrylic resin surfaces. |
Search more.